Global Sintilimab Injection market size is predicted to grow from US$ 169 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Global Sintilimab Injection Market Trends, Growth and Outlook 2025-31

The global Sintilimab Injection market size is predicted to grow from US$ 169 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031. Sintilimab, marketed as TYVYT (sintilimab injection) in China, is a PD-1 immunoglobulin G4 monoclonal antibody co-developed by Innovent and Eli Lilly and Company. Sintilimab is a type of immunoglobulin G4 monoclonal antibody, which binds to PD-1 molecules on the surface of T-cells, blocks the PD-1 / PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells. Innovent is currently conducting more than 20 clinical studies of sintilimab to evaluate its safety and efficacy in a wide variety of cancer indications, including more than 10 registrational or pivotal clinical trials. United States market for Sintilimab Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Sintilimab Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Sintilimab Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Sintilimab Injection players cover Innovant Biologics, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Sintilimab Injection Industry Forecast looks at past sales and reviews total world Sintilimab Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Sintilimab Injection sales for 2025 through 2031. With Sintilimab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sintilimab Injection industry. This Insight Report provides a comprehensive analysis of the global Sintilimab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sintilimab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Sintilimab Injection market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sintilimab Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sintilimab Injection. This report presents a comprehensive overview, market shares, and growth opportunities of Sintilimab Injection market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 100mg/10ml &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Innovant Biologics, Inc. Key Questions Addressed in this Report What is the 10-year outlook for the global Sintilimab Injection market? What factors are driving Sintilimab Injection market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Sintilimab Injection market opportunities vary by end market size? How does Sintilimab Injection break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Sintilimab Injection Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Sintilimab Injection by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Sintilimab Injection by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Sintilimab Injection Segment by Type &nbsp;2.2.1 100mg/10ml &nbsp;2.2.2 Others &nbsp;2.3 Sintilimab Injection Sales by Type &nbsp;2.3.1 Global Sintilimab Injection Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Sintilimab Injection Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Sintilimab Injection Sale Price by Type (2020-2025) &nbsp;2.4 Sintilimab Injection Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 Sintilimab Injection Sales by Application &nbsp;2.5.1 Global Sintilimab Injection Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Sintilimab Injection Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Sintilimab Injection Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Sintilimab Injection Breakdown Data by Company &nbsp;3.1.1 Global Sintilimab Injection Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Sintilimab Injection Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Sintilimab Injection Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Sintilimab Injection Revenue by Company (2020-2025) &nbsp;3.2.2 Global Sintilimab Injection Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Sintilimab Injection Sale Price by Company &nbsp;3.4 Key Manufacturers Sintilimab Injection Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Sintilimab Injection Product Location Distribution &nbsp;3.4.2 Players Sintilimab Injection Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Sintilimab Injection by Geographic Region &nbsp;4.1 World Historic Sintilimab Injection Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Sintilimab Injection Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Sintilimab Injection Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Sintilimab Injection Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Sintilimab Injection Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Sintilimab Injection Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Sintilimab Injection Sales Growth &nbsp;4.4 APAC Sintilimab Injection Sales Growth &nbsp;4.5 Europe Sintilimab Injection Sales Growth &nbsp;4.6 Middle East & Africa Sintilimab Injection Sales Growth 5 Americas &nbsp;5.1 Americas Sintilimab Injection Sales by Country &nbsp;5.1.1 Americas Sintilimab Injection Sales by Country (2020-2025) &nbsp;5.1.2 Americas Sintilimab Injection Revenue by Country (2020-2025) &nbsp;5.2 Americas Sintilimab Injection Sales by Type (2020-2025) &nbsp;5.3 Americas Sintilimab Injection Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Sintilimab Injection Sales by Region &nbsp;6.1.1 APAC Sintilimab Injection Sales by Region (2020-2025) &nbsp;6.1.2 APAC Sintilimab Injection Revenue by Region (2020-2025) &nbsp;6.2 APAC Sintilimab Injection Sales by Type (2020-2025) &nbsp;6.3 APAC Sintilimab Injection Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Sintilimab Injection by Country &nbsp;7.1.1 Europe Sintilimab Injection Sales by Country (2020-2025) &nbsp;7.1.2 Europe Sintilimab Injection Revenue by Country (2020-2025) &nbsp;7.2 Europe Sintilimab Injection Sales by Type (2020-2025) &nbsp;7.3 Europe Sintilimab Injection Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Sintilimab Injection by Country &nbsp;8.1.1 Middle East & Africa Sintilimab Injection Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Sintilimab Injection Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Sintilimab Injection Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Sintilimab Injection Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Sintilimab Injection &nbsp;10.3 Manufacturing Process Analysis of Sintilimab Injection &nbsp;10.4 Industry Chain Structure of Sintilimab Injection 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Sintilimab Injection Distributors &nbsp;11.3 Sintilimab Injection Customer 12 World Forecast Review for Sintilimab Injection by Geographic Region &nbsp;12.1 Global Sintilimab Injection Market Size Forecast by Region &nbsp;12.1.1 Global Sintilimab Injection Forecast by Region (2026-2031) &nbsp;12.1.2 Global Sintilimab Injection Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Sintilimab Injection Forecast by Type (2026-2031) &nbsp;12.7 Global Sintilimab Injection Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Innovant Biologics, Inc. &nbsp;13.1.1 Innovant Biologics, Inc. Company Information &nbsp;13.1.2 Innovant Biologics, Inc. Sintilimab Injection Product Portfolios and Specifications &nbsp;13.1.3 Innovant Biologics, Inc. Sintilimab Injection Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Innovant Biologics, Inc. Main Business Overview &nbsp;13.1.5 Innovant Biologics, Inc. Latest Developments 14 Research Findings and Conclusion

Report	Global Sintilimab Injection Market Growth 2025-2031
Selected License	Multi ID: LPI38872

Buyer Information

Order Summary